STE - STERIS plc

NYSE - NYSE Delayed Price. Currency in USD
122.28
+1.24 (+1.02%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close121.04
Open121.82
Bid0.00 x 800
Ask0.00 x 800
Day's Range121.33 - 122.41
52 Week Range88.81 - 123.50
Volume311,894
Avg. Volume451,473
Market Cap10.343B
Beta (3Y Monthly)0.90
PE Ratio (TTM)38.94
EPS (TTM)3.14
Earnings DateFeb 5, 2019 - Feb 11, 2019
Forward Dividend & Yield1.36 (1.12%)
Ex-Dividend Date2019-02-26
1y Target Est136.83
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of STE earnings conference call or presentation 12-Feb-19 3:00pm GMT

    Q3 2019 STERIS plc Earnings Call

  • STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates
    Zacks5 days ago

    STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates

    STERIS (STE) continues to gain from strength in all business segments in Q3.

  • Steris Corp (STE) Q3 2019 Earnings Conference Call Transcript
    Motley Fool5 days ago

    Steris Corp (STE) Q3 2019 Earnings Conference Call Transcript

    STE earnings call for the period ending December 31, 2018.

  • Steris (STE) Matches Q3 Earnings Estimates
    Zacks6 days ago

    Steris (STE) Matches Q3 Earnings Estimates

    Steris (STE) delivered earnings and revenue surprises of 0.00% and 1.21%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press6 days ago

    Steris: Fiscal 3Q Earnings Snapshot

    On a per-share basis, the Derby, Britain-based company said it had profit of 56 cents. Earnings, adjusted for non-recurring costs, came to $1.26 per share. The results met Wall Street expectations. The ...

  • GlobeNewswire6 days ago

    STERIS Announces Financial Results for Fiscal 2019 Third Quarter

    DERBY, U.K.  - (February 11, 2019) - STERIS plc (STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 third quarter ended December 31, 2018.  Revenue as reported for the quarter increased 5% to $696.2 million compared with $661.9 million in the third quarter of fiscal 2018, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 7% for the third quarter of fiscal 2019.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about Steris PLC.

    Steris PLC NYSE:STEView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for STE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding STE totaled $1.95 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks12 days ago

    Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth

    Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Steris (STE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks18 days ago

    Steris (STE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire19 days ago

    STERIS to Announce Fiscal 2019 Third Quarter Financial Results on February 12, 2019

    DERBY, U.K.  - January 29, 2019- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 third quarter financial ...

  • GlobeNewswire26 days ago

    Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019

    NEW YORK, Jan. 22, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Here's Why You Should Invest in STERIS (STE) Stock Right Now
    Zacks2 months ago

    Here's Why You Should Invest in STERIS (STE) Stock Right Now

    With the acquisition of U.K.-based outsourced sterilization services provider Synergy Health, STERIS (STE) has become the global leader in infection prevention and sterilization.

  • GlobeNewswire2 months ago

    STERIS to Present at the J.P. Morgan Healthcare Conference

    DERBY, U.K.  - December 18, 2018 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the J.P. Morgan Healthcare Conference on Monday, January 7, 2019.   Walt Rosebrough, STERIS`s President and CEO, will present at 3:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.

  • Is Steris Plc (STE) A Good Stock To Buy?
    Insider Monkey2 months ago

    Is Steris Plc (STE) A Good Stock To Buy?

    Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

  • Zacks2 months ago

    STERIS Rides on Favorable Industry Trends, Rivalry a Concern

    STERIS (STE) is currently displaying strong top-line growth on encouraging market trends along with a new product and service portfolio.

  • STERIS (STE) Dips on New Restructuring Plan, Layoff Decision
    Zacks2 months ago

    STERIS (STE) Dips on New Restructuring Plan, Layoff Decision

    STERIS (STE) aims to stop the production of the worst-hit products and move toward the existing manufacturing operations by fiscal 2020.

  • Why Is Steris (STE) Down 0.6% Since Last Earnings Report?
    Zacks2 months ago

    Why Is Steris (STE) Down 0.6% Since Last Earnings Report?

    Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire2 months ago

    STERIS Announces Targeted Restructuring Plan

    STERIS plc (STE) ("STERIS" or the "Company") today announced a targeted restructuring plan, which includes the closure of two manufacturing facilities, one in Brazil and one in England, as well as other actions including product rationalization. The Company will relocate the production of the impacted products to existing manufacturing operations during fiscal 2020. "As a result of reduced demand for certain products and overall capacity in our global manufacturing network, we will rationalize select product offerings and consolidate manufacturing of others," said Walt Rosebrough, STERIS`s President and Chief Executive Officer.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of STE earnings conference call or presentation 6-Nov-18 3:00pm GMT

    Q2 2019 STERIS plc Earnings Call

  • Is STERIS plc’s (NYSE:STE) ROE Of 10% Impressive?
    Simply Wall St.3 months ago

    Is STERIS plc’s (NYSE:STE) ROE Of 10% Impressive?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...

  • Steris (STE) Hits Fresh High: Is There Still Room to Run?
    Zacks3 months ago

    Steris (STE) Hits Fresh High: Is There Still Room to Run?

    Steris (STE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • STERIS (STE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
    Zacks3 months ago

    STERIS (STE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y

    STERIS (STE) continues to gain from strength in all business segments in Q2.